Luoxis Diagnostics, Inc. recently presented three clinical and preclinical findings that feature the company’s proprietary RedoxSYS™ Diagnostic System as a comprehensive, groundbreaking tool for research capable of assessing a patient’s oxidation-reduction potential (ORP) in the event of injury, illness, or stress. The findings were presented as peer-reviewed posters during the recently concluded …
diagnosis
A study entitled “Longitudinal Follow-up of a Cohort of Patients with Incidental Abnormal Magnetic Resonance Imaging Findings at Presentation and Their Risk of Developing Multiple Sclerosis” published in the International Journal of MS Care reports that asymptomatic patients accompanied by Magnetic Resonance Images suggestive of…
Researchers from UC San Francisco, the Broad Institute of MIT and Harvard, and Yale School of Medicine recently developed a software tool that helps researchers understand the complex genetic origins of many autoimmune diseases and, ultimately, to better diagnose and treat them. The study was published yesterday in …
High Level of Multiple Sclerosis Diagnoses Observed Among Patients with Inflammatory Eye Disease
The first and largest study on the association between Multiple Sclerosis (MS) and Uveitis was recently presented at the 18th annual meeting of the American Academy of Ophthalmology. The meeting was held at the McCormick Place in Chicago between October 17-21, 2014. Uveitis is a disorder characterized by inflammation of…
The British National Institute for Health and Care Excellence (NICE) updated their guidelines on the provision of health care for multiple sclerosis (MS) patients in the United Kingdom, which number approximately 100,000 people. The institute recommends now that every patient who is suspected to suffer from the…
Researchers are continuing to make headway in discovering new insights into how MS works, which in turn could lead to next-generation therapies. A new study shows that in the early stages of multiple sclerosis (MS), plasma micro particles act as biomarkers as well as pathological factors that induce endothelial permeability and…
For a 23 year-old country girl from the University of Kentucky to go through the harsh demands of an American beauty pageant, there has to be an inspiration stemming from something more profound than a desire for world peace, a sash, and a shiny crown. Last month, on July 12th,…
While multiple sclerosis is most typically associated with progressively declining physical ability, multiple sclerosis patients are often times affected by a number of physical and mental health comorbidities in addition to their worsening physical ability. This observation was highlighted by a group of researchers in Scotland led by Drs.
According to new research published in European Journal of Neurology, susceptibility to multiple sclerosis may be predicted by looking at individuals’ protein profiles, otherwise known as proteomes. A team led by principal investigator Dr. S. Jacobson at the National Institutes of Health and Dr. M. T.
snig / Shutterstock.com Following yesterday’s publication of “Multiple Sclerosis Management – A Changing Landscape 2013,” a report outlining ongoing goals and focus points for advancing MS drugs and treatments, as a result of a meeting of specialists in Vienna, Austria, a new article…
Recommended Posts
- How a support group opened my eyes to the reality of invisible illness
- EU experts back tolebrutinib approval for SPMS patients with no relapses
- AAN 2026: Ocrevus treatment slows disability in advanced PPMS
- I learn a new lesson about not feeling guilty when good things come my way
- Guest Voice: I’m riding 100 miles a month for the MS community